Koomson Awo Efua, Kukuia Kennedy Kwami Edem, Amoateng Patrick, Biney Robert Peter, Tagoe Thomas Amatey, Mensah Jeffrey Amoako, Ameyaw Elvis Ofori, Torbi Joseph, Amponsah Seth Kwabena
Department of Medical Pharmacology, College of Health Sciences, University of Ghana, Korle Bu, Accra, Ghana.
Department of Pharmacology & Toxicology, School of Pharmacy, College of Health Sciences, University of Ghana, P.O Box LG 43, Legon, Accra, Ghana.
IBRO Neurosci Rep. 2022 Mar 29;12:249-259. doi: 10.1016/j.ibneur.2022.03.006. eCollection 2022 Jun.
Cognitive dysfunction, presenting as learning and memory impairment, is a common manifestation in many chronic diseases of the nervous system. Some of these diseases include depression, epilepsy, and Alzheimer's disease. To date, few drugs or medicinal products have shown ability to improve learning and memory deficits. Neuroprotection is one of the mechanisms by which memory could be improved. The extract of and its kaurene derivative, xylopic acid, have previously demonstrated neuroprotective effects in animal models. The aim of the present study was to investigate the effect of an extract of fruit and xylopic acid, on learning and memory using murine models.
Unripe fruits were collected, dried, and extracted using 70% v/v ethanol. Xylopic acid was isolated from the fruits using petroleum ether, concentrated with ethyl acetate and then recrystallized with petroleum ether before purifying with ethanol (96%/). Institute of Cancer Research (ICR) mice received oral doses of the extract of (XAE; 30, 100 and 300 mg/kg), xylopic acid (XA; 30, 100 and mg/kg), citicoline (300 mg/kg), piracetam (300 mg/kg) or ketamine (30 mg/kg) and saline (vehicle). The animals were then taken through the Morris water maze test (MWM), spontaneous alternation Y-maze test (Y-maze), and novel object recognition test (NOR), to assess learning and memory.
In the NOR test, XAE (30, 100 and 300 mg/kg) and XA (30, 100 and 300 mg/kg) increased the percentage exploration and recognition index (p = 0.0005 and p < 0.0001, respectively) when compared to both vehicle and ketamine groups. Similarly, doses of XAE and XA as used in the NOR test increased the percentage alternation in the Y-maze test. Although XAE and XA treatments decreased the latencies to find hidden platform in the MWM test, it was not significantly different from the vehicle group. However, this decrease in latency differed significantly when compared to the ketamine group. Interestingly, both XAE and XA treatments increased the percentage frequency to the target quadrant in the probe trial of the MWM. It is noteworthy that in all the three models used, both the extract and xylopic acid performed better than piracetam and citicoline, the reference drugs.
The ethanolic extract of fruit and xylopic acid improved exploratory learning and recognition memory, spatial working, recognition, and reference memories in the behavioral tests.
认知功能障碍表现为学习和记忆受损,是许多慢性神经系统疾病的常见症状。其中一些疾病包括抑郁症、癫痫和阿尔茨海默病。迄今为止,很少有药物或药品显示出改善学习和记忆缺陷的能力。神经保护是改善记忆的机制之一。[植物名称]提取物及其贝壳杉烯衍生物木苦酸,此前已在动物模型中显示出神经保护作用。本研究的目的是使用小鼠模型研究[植物名称]果实提取物和木苦酸对学习和记忆的影响。
收集未成熟的[植物名称]果实,干燥后用70%(v/v)乙醇提取。使用石油醚从果实中分离出木苦酸,用乙酸乙酯浓缩,然后用石油醚重结晶,最后用乙醇(96%/)纯化。癌症研究所(ICR)小鼠口服给予[植物名称]提取物(XAE;30、100和300mg/kg)、木苦酸(XA;30、100和300mg/kg)、胞磷胆碱(300mg/kg)、吡拉西坦(300mg/kg)或氯胺酮(30mg/kg)以及生理盐水(赋形剂)。然后让动物进行莫里斯水迷宫试验(MWM)、自发交替Y迷宫试验(Y迷宫)和新物体识别试验(NOR),以评估学习和记忆。
在NOR试验中,与赋形剂组和氯胺酮组相比,XAE(30、100和300mg/kg)和XA(30、100和300mg/kg)提高了探索百分比和识别指数(分别为p =0.0005和p <0.0001)。同样,NOR试验中使用的XAE和XA剂量增加了Y迷宫试验中的交替百分比。虽然XAE和XA处理降低了MWM试验中找到隐藏平台的潜伏期,但与赋形剂组没有显著差异。然而,与氯胺酮组相比,这种潜伏期的降低有显著差异。有趣的是,XAE和XA处理均增加了MWM探针试验中目标象限出现的频率百分比。值得注意的是,在所有使用的三种模型中,提取物和木苦酸的表现均优于参比药物吡拉西坦和胞磷胆碱。
[植物名称]果实乙醇提取物和木苦酸在行为试验中改善了探索性学习和识别记忆、空间工作记忆、识别记忆和参考记忆。